Form 4 Hims & Hers Health, Inc. For: Feb 12 Filed by: Baird Melissa
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Hims and Hers (HIMS) PT Raised to $85 at BTIG
February 18, 2025 5:20 AM ESTBTIG analyst David Larsen raised the price target on Hims and Hers (NYSE: HIMS) to $85.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "Shares of both Hims and Hers Health (HIMS, Buy, $85 PT) and LifeMD (LFMD, Buy, $12 PT) are... More
